P
Procept Biorobotics Corp
NASDAQ:PRCT
Procept Biorobotics Corp
NASDAQ:PRCT
Price:
26.12
USD
-6.04%
Market Closed
Market Cap:
$1.5B
Relative Value
The Relative Value of one PRCT stock under the Base Case scenario is 18.9 USD. Compared to the current market price of 26.12 USD, Procept Biorobotics Corp is Overvalued by 28%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PRCT
Relative Value
Base Case
18.9
USD
Overvaluation 28%
P
Multiples Across Competitors
PRCT Competitors Multiples
Procept Biorobotics Corp Competitors
Procept Biorobotics Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
P
|
Procept Biorobotics Corp
NASDAQ:PRCT
|
1.5B USD | 4.8 | -15.4 | -12.7 | -11.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.8B USD | 4.2 | 28.8 | 16.5 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.2B USD | 16.9 | 59.6 | 45.2 | 55.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129B USD | 5.1 | 39.7 | 20.3 | 24.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 3.2 | 24.3 | 13.4 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.7B USD | 5.1 | 35.1 | 20.6 | 27.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 1.9 | 20.8 | 11.6 | 16.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.1B USD | 8.1 | 45.8 | 25.2 | 27.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.6 | 43 | 30.6 | 33.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.5B USD | 2.1 | 25.9 | 10.2 | 17.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.9B USD | 6.3 | 22.8 | 16 | 17.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
